Taking into account the fact that the known pathogenic variants in LMNA and PPARG account for only 50% of the FPLD cases worldwide, it becomes evident that not only other genes per se, but also other still unknown mutations in these two genes are involved in the pathogenesis of the disease [5]. This evidence concerns the gene LMNA and familial partial lipodystrophy.